[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-362235-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-362235-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","subsequent-primary-and-secondary-neoplasms-in-childhood-cancer-survivors","Subsequent primary and secondary neoplasms in childhood cancer survivors","","Purpose: Count and review subsequent malignant neoplasms (SMNs) in childhood cancer survivors, which are estimated to occur about ten times more often than in the general population. Material and methods: Analyze data of 60 patients with SMNs, including gender, age at index diagnosis, treatment, interval between diagnoses, radio-therapy association, observation time, survival status, and genetic background. Results: Median diagnosis age 6.8 years for the index tumor and 14.9 years for SMNs; 16 irradiated-site cases; cancer predisposition syndromes in 18.3%. Conclusions: Lifelong cancer screening is required, especially with CPS where multiple primary cancers must be considered.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/subsequent-primary-and-secondary-neoplasms-in-childhood-cancer-survivors/362235/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/subsequent-primary-and-secondary-neoplasms-in-childhood-cancer-survivors/362235.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of the study on childhood cancer survivors?","Question",{"text":63,"@type":64},"To count and review subsequent malignant neoplasms (SMNs) in childhood cancer survivors and assess their frequency and characteristics compared with the general population.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What patient and clinical data were analyzed in the material and methods section?",{"text":68,"@type":64},"Data from 60 patients, including gender, age at index diagnosis, treatment, time between diagnoses, whether SMNs were associated with radiotherapy, observation time, survival status, and genetic background.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings relate SMNs timing and risk?",{"text":72,"@type":64},"Median time between first and subsequent neoplasm diagnosis was 6.3 years; in 16 patients secondary tumors developed in irradiated sites; 18.3% had cancer predisposition syndromes, with multiple primary malignancies noted in some cases.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},362235,1790669207,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","© Pol J Radiol 2025; 90: e621-e631 DOI: [https://doi.org/10.5114/pjr/213904](https://doi.org/10.5114/pjr/213904)  \n[Received: 03.11.2025](Received: 03.11.2025)  \n[Accepted: 03.11.2025](Accepted: 03.11.2025)  \n[Published: 27.12.2025](Published: 27.12.2025)  \n[http://www.polradiol.com](http://www.polradiol.com)  \nOriginal paper  \nSubsequent primary and secondary neoplasms in childhood cancer survivors  \nMonika Bekiesińska-Figatowska 1,A,B,C,D,E,F,G\\#, Katarzyna Bilska2,B,C,D,E\\#, Sylwia Szkudlińska-Pawlak1,B,D,E, Teresa Klepacka3,B,D, Anna Raciborska2,B,D, Irena Koch3,B, Elżbieta Michalak3,B,D,E  \n1Department of Diagnostic Imaging, Institute of Mother and Child, Warsaw, Poland  \n2Department of Oncology and Surgical Oncology for Children and Youth, Institute of Mother and Child, Warsaw, Poland 3Department of Pathomorphology, Institute of Mother and Child, Warsaw, Poland  \n\\#These authors contributed equally to this work.  \nAbstract  \nPurpose: To count and review cases of subsequent malignant neoplasms (SMNs) in childhood cancer survivors, which are estimated to occur at a tenfold higher frequency than in the general population.  \nMaterial and methods: Data of 60 patients with SMNs from a tertiary referral center for pediatric solid tumors were analyzed: gender, age at diagnosis, treatment, time between diagnoses, subsequent cancer’s association with radio  \ntherapy, observation time, status: alive/dead, genetic background.  \nResults: Median age at time of diagnosis of the index tumor (IT) was 6.8 years (0.1-22.1), of subsequent neoplasm  \n14.9 years (2.1-36.6) . Median time between diagnosis of first and subsequent neoplasm was 6.3 years (0.8-26.2) . In 16 patients, secondary tumors developed in irradiated sites. Eleven patients (18.3%) had cancer predisposition syndromes (CPS): 3 RB1 mutation, 5 Li-Fraumeni syndrome, 4 neurofibromatosis type 1; one had both Li-Fraumeni syndrome and RB1 mutation. Four patients (3 with CPS) had a third malignant neoplasm, and three had a fourth. Thirty-seven patients (61.6%) are alive, 23 (38.4%) died. Median observation time is 15.0 years (1.3-43.1). The overall 5-year survival rate in the whole group is 85% from diagnosis of IT. The overall 5-year survival rate from diagnosis of the second tumor is 63% .  \nConclusions: Due to risk ofSMNs, life-long cancer screening is required for childhood cancer survivors. In CPS, this risk is multiplied, as it results from both genetic factors and previous treatment; in these patients, multiple primary cancers must be taken into account. When assessing imaging studies of patients with a history of malignancy, clinicians should consider not only recurrence and metastases but also the possibility of a new malignancy of a different histopathological nature.  \nKeywords: childhood cancer survivor, subsequent malignant neoplasm, cancer predisposition syndrome.  \nIntroduction  \nAdvances in diagnosis and treatment of neoplasms have led to higher cure rates with 5-year survival rates reaching approximately 80%[1], but the cost of this progress is that patients who have survived one cancer may develop  \nanother one. Treatment of primary malignant neoplasms is a complex process, divided into three, often complementary components: surgery, chemotherapy, and irradiation. Depending on the age of the patient, type of malignancy, and its stage, an appropriate therapeutic program is introduced. Surgical procedures are the only method  \nCorrespondence address:  \nMonika Bekiesińska-Figatowska, Department of Diagnostic Imaging, Institute of Mother and Child, 17A Kasprzaka St., 01-211 Warsaw, Poland, [e-mail: m.figatowska@mp.pl](e-mail: m.figatowska@mp.pl)  \nAuthors’ contribution:  \nA Study design ∙ B Data collection ∙ C Statistical analysis ∙ D Data interpretation ∙ E Manuscript preparation ∙ F Literature search ∙ G Funds collection  \nThis is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 ","cbCaiapemAUgAT7c","https://ap.wps.com/l/cbCaiapemAUgAT7c","pdf",5914431,11,"English","# Purpose\n# Material and methods\n# Results\n# Conclusions\n# Keywords\n# Introduction","[{\"question\":\"What is the purpose of the study on childhood cancer survivors?\",\"answer\":\"To count and review subsequent malignant neoplasms (SMNs) in childhood cancer survivors and assess their frequency and characteristics compared with the general population.\"},{\"question\":\"What patient and clinical data were analyzed in the material and methods section?\",\"answer\":\"Data from 60 patients, including gender, age at index diagnosis, treatment, time between diagnoses, whether SMNs were associated with radiotherapy, observation time, survival status, and genetic background.\"},{\"question\":\"What key findings relate SMNs timing and risk?\",\"answer\":\"Median time between first and subsequent neoplasm diagnosis was 6.3 years; in 16 patients secondary tumors developed in irradiated sites; 18.3% had cancer predisposition syndromes, with multiple primary malignancies noted in some cases.\"}]","Subsequent primary and secondary neoplasms in childhood cancer survivors | PDF",1790146865,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3e5ee15bb5d46ffc9ed9ff8d5141e2f.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b36184160457552cb9574e54e7de6fec.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15c47216d5196b839f70b122e55658b0.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84f3a8d2510457cd65172c264e1ecdbd.webp",980,1385]